2025 Concordia Annual Summit

Expanding Access & Innovation: Tackling NCDs with Digitally-Enabled Care

  • Health Opportunities & Challenges
Sarah Wells Kocsis, Chris Toth

Session
Partners

Session Summary

Important
Quotations

"850 million people worldwide are affected, which is about 10% of the global population. At the Milken Institute, we've led research showing how kidney disease is consistently characterized as a silent killer."
Sarah Wells Kocsis
"It's underappreciated that by 2040 kidney disease is projected to be the fifth largest killer in the world. A fact that is not well known is that if you're a woman with end-stage kidney disease, you're three times more likely to die than if you're a woman diagnosed with breast cancer."
Chris Toth

Key
Takeaways

  • The Urgency of Kidney Disease: Kidney disease affects 850 million people worldwide, 10% of the global population, and is projected to become the fifth leading cause of death by 2040. Women with end-stage kidney disease are three times more likely to die than those with breast cancer, highlighting a severe gender disparity. Often described as a “silent disease,” it presents no symptoms until it reaches critical stages, “like a locomotive coming through.”

 

  • Technology-Enabled Solutions: Artificial intelligence is revolutionizing kidney care through AI-powered quality control in dialysis, patient communication analysis, and connected device monitoring. Innovations like overnight peritoneal dialysis enable treatment during sleep, preserving cognitive function and quality of life. The cross-sector framework for addressing the crisis rests on three pillars: Innovation, Education, and Evidence.

 

Action
Items

  • For Healthcare Systems: Strengthen infrastructure to support patients with kidney disease and comorbidities, and integrate care models to ensure seamless coordination across all treatment settings.

 

  • For Technology Companies: Scale AI applications beyond manufacturing to patient communication and clinical support, and develop connected ecosystems that integrate real-time device data with clinical expertise.

 

  • For Policymakers: Create reimbursement frameworks that reward the adoption of innovative home dialysis technologies and launch targeted education initiatives tailored to specific national contexts.

 

  • For Global Health Community: Build a robust evidence base demonstrating the clinical and economic benefits of digitally enabled kidney care. Foster cross-sector partnerships linking private industry, governments, and healthcare providers, while ensuring that technological innovations reach underserved populations facing the greatest health disparities.

Important
Notice

You are currently on Concordia’s official website: www.concordia.net

We have identified a fraudulent website operating under

www.theconcordiasummit.org

that is impersonating Concordia and using our brand, language, and images without authorization. This site is not affiliated with Concordia. If you have shared personal or payment information with that website, please contact us immediately at enquiries@concordia.net. We are actively working to have the site removed.